<DOC>
	<DOC>NCT00734045</DOC>
	<brief_summary>The primary objective of the study is to establish the correlation between NT-proBNP measurements in fresh human whole blood samples and those in plasma samples from the same study subjects, where said samples are collected in EDTA and Li-Hep anticoagulant tubes and measured by the StatusFirst™ CHF NT-proBNP device in conjunction with the DXpressTM Reader in a laboratory setting.</brief_summary>
	<brief_title>Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Have clinically confirmed heart failure (NYHA class IIV) or have presented to an emergency room or clinic with signs, symptoms and/or risk factors suggestive of heart failure, OR Be nonCHF controls greater than 45 years of age with no history of heart failure or cardiovascular disease. Be 45 years of age or younger</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Congestive Heart Failure (CHF)</keyword>
	<keyword>NT-proBNP</keyword>
</DOC>